E3ligaseLigand-LinkerConjugates33Hydrochloride
98%
- Product Code: 106191
CAS:
1239866-59-1
| Molecular Weight: | 654.19 g./mol | Molecular Formula: | C₃₅H₄₄ClN₃O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
E3ligaseLigand-LinkerConjugates33Hydrochloride is primarily utilized in the field of targeted protein degradation, a cutting-edge approach in drug discovery and development. This compound is designed to facilitate the degradation of specific proteins by harnessing the ubiquitin-proteasome system. It works by binding to a target protein and recruiting an E3 ubiquitin ligase, which tags the protein for degradation by the proteasome. This mechanism is particularly valuable in addressing diseases caused by the overexpression or malfunction of specific proteins, such as certain cancers, neurodegenerative disorders, and autoimmune conditions. Its application extends to the development of PROTACs (Proteolysis Targeting Chimeras), a novel class of therapeutic agents that offer advantages over traditional small molecule inhibitors by enabling the complete removal of disease-causing proteins rather than merely inhibiting their activity. This compound's linker component ensures optimal spatial orientation and stability, enhancing its efficacy in biological systems.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿16,200.00 |
+
-
|
E3ligaseLigand-LinkerConjugates33Hydrochloride
E3ligaseLigand-LinkerConjugates33Hydrochloride is primarily utilized in the field of targeted protein degradation, a cutting-edge approach in drug discovery and development. This compound is designed to facilitate the degradation of specific proteins by harnessing the ubiquitin-proteasome system. It works by binding to a target protein and recruiting an E3 ubiquitin ligase, which tags the protein for degradation by the proteasome. This mechanism is particularly valuable in addressing diseases caused by the overexpression or malfunction of specific proteins, such as certain cancers, neurodegenerative disorders, and autoimmune conditions. Its application extends to the development of PROTACs (Proteolysis Targeting Chimeras), a novel class of therapeutic agents that offer advantages over traditional small molecule inhibitors by enabling the complete removal of disease-causing proteins rather than merely inhibiting their activity. This compound's linker component ensures optimal spatial orientation and stability, enhancing its efficacy in biological systems.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :